Strict glycaemic control improves skin microcirculation in patients with type 2 diabetes: a report from the Diabetes mellitus And Diastolic Dysfunction (DADD) study

Diab Vasc Dis Res. 2012 Oct;9(4):287-95. doi: 10.1177/1479164111432182. Epub 2012 Feb 29.

Abstract

Background: Microcirculatory and endothelial dysfunction are signs of cardiovascular engagement in patients with type 2 diabetes. This study tested whether glucose normalisation may reverse this.

Methods: Thirty-nine T2DM patients (age 61±7 years, 58% females) with signs of mild diastolic dysfunction were randomised to strict glucose control based on insulin (I-group; n=21) or oral agents (O-group; n=18) for four months. Skin microcirculation was studied with laser Doppler fluxmetry and endothelial function with brachial artery flow-mediated dilatation.

Results: Glucose control improved (reduction of HbA(1c) I-group = -0.5%; O-group -0.7%; p=0.69). Microcirculation improved in the entire group (n=39) determined by foot laser Doppler fluxmetry (32.2±13.6 vs. 35.3±13.1 perfusion units; p<0.001) and laser Doppler fluxmetry following heating (68.8±34.0 vs. 69.3±25.1 PU; p=0.007). Improvement was more consistent with oral agents than insulin. Endothelial function expressed as flow-mediated dilatation decreased in the I-group (6.0±2.2 to 4.7±3.0%; p=0.037) but remained unchanged in the O-group (4.8±2.3 to 5.0±3.7%; n.s.).

Conclusions: Glycaemic normalisation improved skin microcirculation but not endothelial function in patients with type 2 diabetes with mild cardiovascular engagement.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Aged
  • Biomarkers / blood
  • Blood Glucose / drug effects*
  • Blood Glucose / metabolism
  • Brachial Artery / drug effects
  • Brachial Artery / physiopathology
  • Carbamates / therapeutic use
  • Diabetes Mellitus, Type 2 / blood
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Diabetes Mellitus, Type 2 / physiopathology
  • Diabetic Angiopathies / blood
  • Diabetic Angiopathies / drug therapy*
  • Diabetic Angiopathies / etiology
  • Diabetic Angiopathies / physiopathology
  • Diastole*
  • Female
  • Glycated Hemoglobin / metabolism
  • Humans
  • Hypoglycemic Agents / administration & dosage
  • Hypoglycemic Agents / therapeutic use*
  • Insulin Aspart / therapeutic use
  • Insulin Glargine
  • Insulin, Long-Acting / therapeutic use
  • Laser-Doppler Flowmetry
  • Male
  • Metformin / therapeutic use
  • Microcirculation / drug effects*
  • Middle Aged
  • Piperidines / therapeutic use
  • Prospective Studies
  • Regional Blood Flow / drug effects
  • Skin / blood supply*
  • Sweden
  • Time Factors
  • Treatment Outcome
  • Vasodilation / drug effects
  • Ventricular Dysfunction / etiology
  • Ventricular Dysfunction / physiopathology*
  • Ventricular Function*

Substances

  • Biomarkers
  • Blood Glucose
  • Carbamates
  • Glycated Hemoglobin A
  • Hypoglycemic Agents
  • Insulin, Long-Acting
  • Piperidines
  • hemoglobin A1c protein, human
  • Insulin Glargine
  • repaglinide
  • Metformin
  • Insulin Aspart